In my 40 years of biotech, I was waiting to see this result. Never before have transplanted cells survived normal immune response without immunosuppression. Excited for patients, many whom I know see hope today for a possible cure for many diseases. globenewswire.com/news-release/2…

The #H5N1 outbreak is very concerning despite assurances from public health officials. A novel flu virus for which humans have no background immunity is a formidable foe. Let’s hope the incoming team moves swiftly to build the array of required countermeasures.

Excellent choice. Gerald Parker is experienced and clear-eyed about the threats we face. One of his favorite sayings is “let’s not wish the threat away.”

NIH 2025 summer internships cancelled. This really sucks. NIH internships have launched many scientific careers. At a time when the U.S. is discouraging foreign students, how can it make sense to kill a program that costs pennies and is critical to building homegrown scientists?

Today, Paradigm Health, Inc. is announcing a dedicated effort to expand clinical trial access in rural America, with former United States Secretary of Veterans Affairs David J. Shulkin, MD joining as an advisor. paradigm.inc/news/david-shu…

Thank you Martin Giles for hosting @drewendy.bsky.social and me for this episode. I always learn so much from Drew.

My latest piece on STAT with Philip R. Krause, M.D. about steps to improve U.S. FDA

My latest piece with Philip R. Krause, M.D. about political interference at U.S. FDA. Its impact goes well beyond vaccines.

With ambiguous and scientifically unsupported statements on the Novavax COVID vaccine HHS, FDA have allowed politics to override public health. The consequences won't be limited to vaccines. biocentury.com/article/655774

How to stop the shift of drug discovery from the U.S. to China Via Scott Gottlieb, MD 🇺🇸 statnews.com/2025/05/06/how…

Another window into points I made in this op ed yesterday, about Chinese biotech displacing U.S. innovation: China’s share of clinical trial starts dramatically increased — from 1% to 30% over last decade, and Chinese biotech companies are poised to overtake U.S. counterparts

Good read from Vinay Prasad MD MPH & Marty Makary MD, MPH: nejm.org/doi/full/10.10… — Public trust in vax has fallen, driving hesitancy even around proven shots like MMR, long established as safe & highly effective.

“There are new cures for cancer that need to be uncovered, new discoveries waiting to be made, more lives to be saved that previously were unsavable. This will happen when truth is prioritized, when science is protected, and when people come first.” Prof Odunsi

Stirring up good trouble at #BIO2025 with the brilliant Esper Kallas of Instituto Butantan — the powerhouse driving vaccine innovation for Brazil, Latin America, and the world.